The frail body of 11-year-old Harry Brendel is burdened by an enigmatic secret.
Massachusetts mother seeks solutions for son facing progressive mobility challenges.
The frail body of 11-year-old Harry Brendel is burdened by an enigmatic secret.
Revised: 8:20 PM EST January 9, 2025
Massachusetts mother seeks solutions for son facing progressive mobility challenges.
The frail body of 11-year-old Harry Brendel is burdened by an enigmatic secret.
Revised: 8:20 PM EST January 9, 2025
Harry Brendel, an 11-year-old boy from Massachusetts, is facing a gradual decline in mobility due to an undiagnosed medical issue. His mother, Kelsey, is reaching out for help from the Undiagnosed Diseases Network (UDN), a research program backed by the National Institutes of Health (NIH) that seeks to provide answers for families dealing with unexplained health conditions. In tribute to Harry, Kelsey has been actively raising funds to support the Center for Courageous Kids at Mass General Hospital for Children. The UDN unites clinical and research professionals from across the United States to address complex medical enigmas through cutting-edge technologies. Established in 2014, the network features multiple clinical sites nationwide, including one at Massachusetts General Hospital.
Harry Brendel, an 11-year-old boy from Massachusetts, has experienced a progressive loss of mobility due to a medical condition that so far has gone undiagnosed. His mother, Kelsey, is seeking assistance from the Undiagnosed Diseases Network (UDN), a research initiative funded by the National Institutes of Health (NIH) that aims to provide answers for patients and families affected by mysterious conditions. In honor of Harry, Kelsey has worked to raise funds to support the Center for Courageous Kids
at Massachusetts General Hospital for Children.
The Undiagnosed Diseases Network brings together clinical and research experts from across the United States to tackle challenging medical mysteries using advanced technologies. It was established in 2014 and has multiple clinical sites nationwide, including one at Massachusetts General Hospital.
